Trademark: 97285545
Word
EGRIFTA WR
Status
Pending
Status Code
653
Status Date
Monday, February 12, 2024
Serial Number
97285545
Mark Type
4000
Filing Date
Friday, February 25, 2022

Trademark Owner History

Classifications
5 Pharmaceutical preparations for the treatment of lipodystrophy, obesity, wasting, growth hormone deficiency, cognitive impairment, traumatic brain injury, nonalcoholic steathohepatitis and nonalcoholic fatty liver disease

Trademark Events
Feb 12, 2024
Notification Of Letter Of Suspension E-Mailed
Feb 12, 2024
Letter Of Suspension E-Mailed
Feb 12, 2024
Suspension Letter Written
Feb 12, 2024
Teas/Email Correspondence Entered
Feb 12, 2024
Correspondence Received In Law Office
Feb 12, 2024
Assigned To Lie
Sep 21, 2023
Teas Response To Suspension Inquiry Received
Jul 3, 2023
Notification Of Inquiry As To Suspension E-Mailed
Jul 3, 2023
Inquiry To Suspension E-Mailed
Jul 3, 2023
Suspension Inquiry Written
Jun 28, 2023
Suspension Checked - To Attorney For Action
Dec 12, 2022
Notification Of Letter Of Suspension E-Mailed
Dec 12, 2022
Letter Of Suspension E-Mailed
Dec 12, 2022
Suspension Letter Written
Dec 8, 2022
Assigned To Examiner
Mar 3, 2022
New Application Office Supplied Data Entered
Mar 1, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24